Travis Young is a Venture Partner at Foresite Labs, where he leads therapeutics strategy. He previously spent 14 years at Scripps Research and Calibr-Skaggs, and holds a PhD from Scripps Research, with postdoctoral training at Harvard Medical School.
At firms with a similar stage, sector and check size.



One email when Travis's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckTravis Young is a Venture Partner at Foresite Labs, where he leads therapeutics strategy. He previously spent 14 years at Scripps Research and Calibr-Skaggs, and holds a PhD from Scripps Research, with postdoctoral training at Harvard Medical School.
Foresite Capital has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder Foresite Capital backed works best.
Graduate Faculty Member at Scripps Research; Executive Vice President at Calibr-Skaggs; Venture Partner at Foresite Labs; Executive Vice President, Director at Calibr-Skaggs Institute for Innovative Medicines; Chief Scientific Officer, Therapeutics at Foresite Labs.
Last updated 2026-10-15. Is this you? Ask for a correction.